CORZCore Scientific, Inc./tx
Finance Services
- Revenue
- $319M
- 38% YoY
- Operating margin
- -77.0%
- 177% YoY
- EBITDA
- −$177M
- 512% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- $286M net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCFired31% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear0% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $544M | $640M | $502M | $511M | $319M | 38% |
| Operating income | $131M | −$2.1B | $9M | −$142M | −$246M | 73% |
| Net income | $47M | −$2.1B | −$246M | −$1.4B | −$289M | 80% |
| Operating cash flow | −$57M | $205M | $65M | $43M | $278M | 549% |
| Capex | $0 | $384M | $16M | $95M | $729M | 668% |
| Stock-based comp | $39M | $183M | $59M | $52M | $98M | 89% |
| Buybacks | — | $32M | $0 | $0 | — |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $98K · 1
- Open-market sells, 12 mo
- $1M · 9
- Net
- −$1M
Pay vs performance
No pay-versus-performance disclosure yet.